Home > Insider Trading > Filing (0000899243-19-023317)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1341235	Aldeyra Therapeutics Inc.	ALDX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579179	C Todd Brady	C/O Aldeyra Therapeutics, Inc. 131 Hartwell Avenue Lexington MA 02421	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-09	10,000	$4.89	568,991	No	4	P	Direct
Common Stock	Acquisiton	2019-09-10	10,000	$5.39	578,991	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.88 to $4.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Includes 2,937 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.375 to $5.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4.